Moderna and IBM Explore Quantum and Generative AI for mRNA Science

CAMBRIDGE, MA and ARMONK, NY / April 20, 2023 / Moderna, Inc. (Nasdaq: MRNA), a biotechnology company focused on messenger RNA (mRNA) therapeutics and vaccines, and IBM (NYSE: IBM) have announced an agreement under which Moderna will explore next generation technologies, including quantum computing and artificial intelligence, to advance mRNA research and science. “Since our […]